IGC Pharma (IGC) Amortizatization of Intangibles (2020 - 2022)

IGC Pharma (IGC) has reported Amortizatization of Intangibles for 3 consecutive years, with $26000.0 the latest figure, recorded in Q3 2022.

• On a quarterly basis, Amortizatization of Intangibles changed 0.0% year-over-year to $26000.0 in Q3 2022; TTM through Sep 2022 was $116000.0, a 107.14% increase from a year earlier, with the FY2022 full-year figure at $115000.0, up 422.73% from the prior year.
• Amortizatization of Intangibles was $26000.0 for Q3 2022 at IGC Pharma, down from $28000.0 in the prior quarter.
• Over five years, Amortizatization of Intangibles peaked at $35000.0 in Q1 2022 and troughed at -$2000.0 in Q3 2020.
• A 3-year average of $19100.0 and a median of $26000.0 in 2021 frame the typical range for Amortizatization of Intangibles.
• Across the five-year window, Amortizatization of Intangibles soared 2600.0% in 2021 and changed 0.0% in 2022, its largest moves.
• Over 3 years, Amortizatization of Intangibles stood at $1000.0 in 2020, then soared by 2600.0% to $27000.0 in 2021, then slipped by 3.7% to $26000.0 in 2022.
• The last three Amortizatization of Intangibles figures came in at $26000.0 (Q3 2022), $28000.0 (Q2 2022), and $35000.0 (Q1 2022), per Business Quant data.